Effects of 5HT2 receptor antagonists on responses to potassium depolarization in rat isolated aorta

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 1, 1997, Pages 34-39

  Okoro, E O ^a,b   Marwood, J F ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

5HT2 receptor antagonists; Ca2+ uptake blockers; rat aorta; voltage operated calcium channels

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; CYPROHEPTADINE; DILTIAZEM; FELODIPINE; KETANSERIN; MIANSERIN; NIFEDIPINE; POTASSIUM; PRAZOSIN; RITANSERIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; VERAPAMIL; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM METABOLISM; DEPOLARIZATION; NONHUMAN; RAT; SMOOTH MUSCLE; ANIMAL; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; MALE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; REPRODUCIBILITY; SPRAGUE DAWLEY RAT; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; CINNARIZINE; CYPROHEPTADINE; DILTIAZEM; DRUG SYNERGISM; FELODIPINE; FEMALE; KETANSERIN; MALE; MIANSERIN; MUSCLE CONTRACTION; NIFEDIPINE; POTASSIUM; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; REPRODUCIBILITY OF RESULTS; RITANSERIN; SEROTONIN ANTAGONISTS; VERAPAMIL;

EID: 0030614741     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01780.x     Document Type: Article

References (37)

1. 2+, verapamil and ketanserin in rat tail artery and aorta. J. Cardiovasc. Pharmacol. 1995; 25: 603-10.
2. Van Nueten JM, Vanhoutte PM. Selectivity of calcium antagonism and serotonin antagonism with respect to venous and arterial tissues. Angiology 1981; 32: 476-84.
3. Sinanovac O, Shigetoshi C. Pharmacological analysis of 5HT-induced vasoconstriction in isolated perfused dog skeletal muscle arteries. Eur. J. Pharmacol. 1987; 143: 353-60.
4. Kotake H, Hirrai S, Kobayashi M et al. Effects of Ketanserin on the pacemaker activity of rabbit sinus node in vitro. Pharmacology 1989; 38: 40-6.
5. Hof RP, Vuorela HJ. Assessing calcium antagonism on vascular muscle: A comparison of three methods. J. Pharmacol. Methods 1983; 9: 41-52.
6. 2+ channels in rat aorta. Eur. J. Clin. Pharmacol. 1986; 175: 261-71.
7. Papaionnou S, Panzer-knodle S, Yang PC. Calcium channel blockers: Correlation among receptor binding, calcium uptake and contractility in vitro. J. Pharmacol. Exp. Ther. 1987; 241: 91-6.
8. Shibata R, Morita S, Nagai K, Miyata S, Iwasaki T. Effects of H-7 (protein kinase inhibitor and phorbol ester) on aortic strips from spontaneous hypertensive rat. Eur. J. Pharmacol. 1990; 175: 261-71.
9. 2+ channels. Clin. Exp. Pharmacol. Physiol. 1991; 18(Suppl. 8): 47.
10. 2 receptor and calcium channels in rat isolated aortae. MSc Thesis, University of Sydney, New South Wales, Australia. 1992.
11. 2+ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries. Circ. Res. 1983; 52 (Suppl. 1): 81-91.
12. 2+ uptake in the smooth muscle of rabbit aorta, rat aorta and guinea-pig taenia coli. Br. J. Pharmacol. 1984; 81: 393-400.
13. Doggrell SA, Paton DM. Effects of time and initial concentration of agonist on contractile responses in rat aortae. J. Pharmacol. Methods 1978; 1: 115-19.
14. Wright G. Use-dependent decline in rat aorta sensitivity to contraction by potassium. Can. J. Physiol. Pharmacol. 1991; 69: 921-8.
15. Kreye VAW, Barron GD, Luth JB, Schmidt-Gay KH. Mode of action of sodium nitroprusside in vascular smooth muscle. Naunyn Schmiedeberg's Arch. Pharmacol. 1975; 288: 381-402.
16. Winquist RJ, Siegl PKS, Baskin EP, Bohn DL, Morgan G, Wallace AA. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparation. J. Pharmacol. Exp. Ther. 1984; 230: 103-9.
17. Marriot JF. A comparison of the effects of the calcium entry blockers: Verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein. Br. J. Pharmacol. 1988; 95: 145-55.
18. +-induced contractions in the rat aorta. J. Auton. Pharmacol. 1989; 9: 329-36.
19. 2+ antagonists. Gen. Pharmacol. 1991; 22: 177-81.
20. Nyborg NCB, Mulvany MJ. Effect of felodipine, a new dihydropyridine vasodilator on contractile response to potassium, noradrenaline and calcium in mesenteric resistance vessels in the rat. J. Cardiovasc. Pharmacol. 1984; 6: 499-505.
21. 2+ dependence and diltiazem inhibition of contraction in rabbit conduit arteries and mesenteric resistance vessels. Blood Vessels 1984; 21: 23-31.
22. 2+ handling along the arterial tree: An update including studies in human mesenteric resistance vessels. J. Cardiovasc. Pharmacol. 1988; 12: S10-15.
23. Beckeringh JJ, Thoolen MJMC, deJong A, Wilffert B, Timmermans PBMWM, Van Zwieten P. Differential effects of the calcium entry blocker D600 on contractions of rat and calcium infux in rat aorta and mesenteric arteries. J. Pharmacol. Exp. Ther. 1984; 229: 515-21.
24. Godfraind T, Dieu D. The inhibition by flunarizine of norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries. J. Pharmacol. Exp. Ther. 1981; 217: 510-15.
25. Towart R. The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium antagonistic dihydropyridines. Circ. Res. 1981; 48: 650-7.
26. Johnson JD, Fugman DA. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segment. J. Pharmacol. Exp. Ther. 1983; 226: 330-4.
27. Haeusler G. Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J. Pharmacol. Exp. Ther. 1972; 180: 672-82.
28. 2-adrenergic receptors. Circ. Res. 1983; 52: 226-31.
29. Jandhyala BS. Studies on the effects of felodipine on the vascular resistance and reactivity in pentobarbital anaesthetized dogs. Naunyn Schmiedeberg's Arch. Pharmacol. 1985; 329: 398-403.
30. Peroutka SJ, Allen GS. The calcium antagonist properties of cyproheptadine: Implications for antimigraine action. Neurology 1984; 34: 304-9.
31. Lowe DA, Mathews EK, Richardson BP. The calcium antagonistic effects of cyproheptadine on contraction, membrane electrical events and calcium influx in the guinea pig taenia coli. Br. J. Pharmacol. 1981; 74: 651-63.
32. Wu K, Hunter TL, Proakis AG. Effects of ritanserin on trans-membrane action potentials in canine purkinje fibres. Proc. Soc. Exp. Biol. Med. 1992; 199: 88-92.
33. Da la Lande IS, Cannell VA, Waterson JO. The interaction of serotonin and noradrenaline on the perfused rabbit ear artery. Br. J. Clin. Pharmacol. Chemother. 1966; 28: 255-72.
34. Leff P, Morse JM. Resultant pharmacological actions of verapamil: Quantification of 5-hydroxytryptamine antagonism in combination with calcium antagonism. J. Pharmacol. Exp. Ther. 1987; 240: 284-7.
35. Nield TO, Kotecha N. Relation between membrane potential and contractile force in smooth muscle of the rat tail artery during stimulation by norepinephrine, 5-hydroxytryptamine and potassium. Circ. Res. 1987; 60: 791-5.
36. Hondeghem LM, Ayad MJ, Robertson RM. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contracted rabbit aorta and porcine coronary arteries. J. Pharmacol. Exp. Ther. 1986; 239: 808-13.
37. Barret VJ, Leff P, Martin GP, Richardson PJ. Pharmacological analysis of the interaction between Bay K 8644 and 5HT in rabbit aortae. Br. J. Pharmacol. 1986; 87: 487-94.